Media coverage
4
Media coverage
Title Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision Media name/outlet PR Newswire Country/Territory United States Date 3/06/19 URL https://www.prnewswire.com/news-releases/secondary-analysis-of-landmark-tailorx-results-published-today-in-the-new-england-journal-of-medicine-affirms-unique-ability-of-oncotype-dx-breast-recurrence-score-to-predict-chemotherapy-benefit-guiding-adjuvant-therapy-with--300860397.html Persons Joseph Sparano Title Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision Media name/outlet Morningstar.com Country/Territory United States Date 3/06/19 URL https://www.morningstar.com/news/pr-news-wire/PRNews_20190603SF70509/secondary-analysis-of-landmark-tailorx-results-published-today-in-the-new-england-journal-of-medicine-affirms-unique-ability-of-oncotype-dx-breast-recurrence-score-to-predict-chemotherapy-benefit-guiding-adjuvant-therapy-with-even-greater-precision.html Persons Joseph Sparano Title Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision Media name/outlet TickerTech.com Country/Territory United States Date 3/06/19 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=201906201906031145PR_NEWS_USPR_____SF70509 Persons Joseph Sparano Title Secondary Analysis of Landmark TAILORx Results... Media name/outlet ADVFN Deutschland Country/Territory Germany Date 3/06/19 URL de.advfn.com/p.php?pid=nmona&article=80049323 Persons Joseph Sparano